Beyond Training: Expanding Primary Care Capacity for Hepatitis C Treatment in an Integrated Health System Serving Southwest Virginia

Clicks: 1
ID: 338127
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #317 of 318 articles by views in Open forum infectious diseases

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 318 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background Chronic hepatitis C virus (HCV) infection remains a major challenge in rural US communities, where limited specialist availability restricts access to effective direct-acting antivirals (DAAs). Primary care-based HCV treatment models are clinically effective, yet uptake remains low. We implemented a training and care coordination program within our southwest Virginia health system to address this gap. Methods We conducted a retrospective pre-post evaluation of an HCV program initiated in June 2023, comprising educational modules, webinar series, specialist consultation, and a dedicated HCV Coordinator. Adults with a qualifying HCV RNA result who initiated DAA therapy between January 1, 2022, and February 28, 2025, were included; prescribing providers were grouped by specialty (Family Medicine, Internal Medicine, or Specialist). The primary outcome was expansion of FM treatment capacity. Secondary outcomes included travel distance and time to treatment. Results Of 828 candidate patients, 587 met eligibility criteria. FM providers initiating DAA therapy increased from 12 to 31, and clinic sites from 6 to 17. FM treatment volume increased from 13 to 40 patients (+208%), a significantly greater increase than other specialties combined (OR=2.90, p<0.001). Most newly involved FM prescribers engaged with the program, via the HCV Coordinator. Compared with specialist care, patients treated in FM had shorter travel distances (5.9 vs 18.9 miles; p<0.001) and a non-significantly shorter time to initiation (44 vs 71 days; p=0.15). Conclusions A multifaceted implementation program combining provider education with centralized care coordination was associated with targeted expansion of FM treatment capacity and improved geographic access to HCV care.
Reference Key
openalex_W7225098295 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Mariana Gomez de la Espriella, Anthony W. Baffoe-Bonnie, Christopher Peterson, Jason R. Faulhaber, Cara Ravagli, Elizabeth S. Nowak, John W. Epling, Marrieth G Rubio
Are you one of these authors? Claim your profile
Journal Open forum infectious diseases
Year 2026
DOI
10.1093/ofid/ofag716
URL
https://doi.org/10.1093/ofid/ofag716
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.